2017
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation
Wyrembak J, Campbell KB, Steinberg BA, Bahnson TD, Daubert JP, Velazquez EJ, Samad Z, Atwater BD. Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. The American Journal Of Cardiology 2017, 119: 1017-1022. PMID: 28153350, DOI: 10.1016/j.amjcard.2016.12.008.Peer-Reviewed Original ResearchConceptsRoutine transesophageal echocardiographyAtrial appendage thrombusLAA thrombusTransesophageal echocardiographyVASc scoreAppendage thrombusNonvitamin K oral anticoagulantsLeft atrial appendage thrombusSingle-center retrospective studyLower LAA velocityTEE-related complicationsOral anticoagulant therapyAtrial fibrillation ablationLAA velocityNOAC therapyOral anticoagulantsAF ablationAnticoagulant therapyCatheter ablationFibrillation ablationAtrial fibrillationRetrospective studyTEE procedureLower incidenceNOACs
2012
Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting
Han SY, Palmeri ST, Broderick SH, Hasselblad V, Rendall D, Stevens S, Tenaglia A, Velazquez E, Whellan D, Wagner G, Heitner JF. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting. Journal Of Electrocardiology 2012, 46: 45-50. PMID: 23063241, DOI: 10.1016/j.jelectrocard.2012.08.011.Peer-Reviewed Original ResearchConceptsNonvalvular atrial fibrillationQuality of anticoagulationAtrial fibrillationTherapeutic rangeStroke preventionPrimary careCardiology practiceRecent large randomized control trialsNew oral anticoagulation agentsPrimary care practice patientsCardiovascular disease risk factorsOne-year periodTreatment of AFInternational normalized ratio (INR) valuesLarge randomized control trialsOral anticoagulation agentsMean therapeutic rangeOral anticoagulation therapyDisease risk factorsPrimary care practicesNovel pharmacologic agentsMulti-center studyCurrent clinical practiceRandomized control trialPrimary care groups